PharmaLifeScience News

...

MSD rumoured to be eyeing $3bn+ MoonLake takeover

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports.

READ MORE
...

Roche takes new antibiotic into phase 3 for 'urgent threat'

Roche takes new antibiotic into phase 3 for 'urgent threat'Phil.TaylorTue, 27/05/2025 - 07:49Bookmark thisPhil.TaylorTue, 27/05/2025 - 07:49Bookmark this
READ MORE
...

Sanofi to buy US blood disorder drugmaker for up to $9.5bn

French company’s purchase of Blueprint Medicines boosts immunology pipeline
READ MORE